| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |